Invokana Amputation Risk Does Not Apply, J&J Competitors
Even as Johnson & Johnson rushes to comply with new FDA requirements to warn consumers about the Invokana amputation risk, the company's competitors are working just as hard to separate themselves from J&J's medication. Both AstraZeneca (Farxiga) and Eli Lilly/Boeheringer…